The GnRH Receptor Antagonists market size is expected to reach $2.38 billion in 2030 at a CAGR of 8.5%, driven by increasing prevalence of hormone-related disorders.
Read More
The GnRH Agonists And Antagonists Drugs market size is expected to reach $2.72 billion in 2030 at a CAGR of 9.4%, driven by increasing ovarian and prostate cancers.
Read More
The Glycopeptide Antibiotics market size is expected to reach $5.89 billion in 2030 at a CAGR of 9.3%, driven by increasing prevalence of gram-positive infections.
Read More
The GLP-1 Receptor Agonist market size is expected to reach $18.32 billion in 2030 at a CAGR of 5.4%, driven by rising prevalence of diabetes.
Read More
The Genomic Cancer Panel And Profiling market size is expected to reach $15.45 billion in 2030 at a CAGR of 8.4%, driven by rising cancer incidence.
Read More
The Genomic Biomarker market size is expected to reach $22.23 billion in 2030 at a CAGR of 17.5%, driven by increasing prevalence of chronic diseases.
Read More
The Genome Sequencing market size is expected to reach $28.07 billion in 2030 at a CAGR of 18.9%, driven by increasing occurrence of cancer.
Read More
The Genitourinary Drugs market size is expected to reach $35.69 billion in 2030 at a CAGR of 2.8%, driven by growing prevalence of genitourinary disorders.
Read More
The Genetic Mutation Analysis market size is expected to reach $11.47 billion in 2030 at a CAGR of 11.5%, driven by rising prevalence of genetic disorders.
Read More
The Genetic Analysis market size is expected to reach $18.75 billion in 2030 at a CAGR of 12.7%, driven by increasing cases of cancer.
Read More